BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 20046661)

  • 1. Medical implications of obesity in horses--lessons for human obesity.
    Johnson PJ; Wiedmeyer CE; Messer NT; Ganjam VK
    J Diabetes Sci Technol; 2009 Jan; 3(1):163-74. PubMed ID: 20046661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The equine metabolic syndrome peripheral Cushing's syndrome.
    Johnson PJ
    Vet Clin North Am Equine Pract; 2002 Aug; 18(2):271-93. PubMed ID: 15635908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes, insulin resistance, and metabolic syndrome in horses.
    Johnson PJ; Wiedmeyer CE; LaCarrubba A; Ganjam VK; Messer NT
    J Diabetes Sci Technol; 2012 May; 6(3):534-40. PubMed ID: 22768883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From Table to Stable: A Comparative Review of Selected Aspects of Human and Equine Metabolic Syndrome.
    Ragno VM; Zello GA; Klein CD; Montgomery JB
    J Equine Vet Sci; 2019 Aug; 79():131-138. PubMed ID: 31405493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomewide association study reveals a risk locus for equine metabolic syndrome in the Arabian horse.
    Lewis SL; Holl HM; Streeter C; Posbergh C; Schanbacher BJ; Place NJ; Mallicote MF; Long MT; Brooks SA
    J Anim Sci; 2017 Mar; 95(3):1071-1079. PubMed ID: 28380523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cushing's syndromes, insulin resistance and endocrinopathic laminitis.
    Johnson PJ; Messer NT; Ganjam VK
    Equine Vet J; 2004 Apr; 36(3):194-8. PubMed ID: 15147123
    [No Abstract]   [Full Text] [Related]  

  • 7. The prevalence of endocrinopathic laminitis among horses presented for laminitis at a first-opinion/referral equine hospital.
    Karikoski NP; Horn I; McGowan TW; McGowan CM
    Domest Anim Endocrinol; 2011 Oct; 41(3):111-7. PubMed ID: 21696910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary management of obesity and insulin resistance: countering risk for laminitis.
    Geor RJ; Harris P
    Vet Clin North Am Equine Pract; 2009 Apr; 25(1):51-65, vi. PubMed ID: 19303550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic, hormonal, and clinical characteristics of equine endocrinopathic laminitis.
    de Laat MA; Sillence MN; Reiche DB
    J Vet Intern Med; 2019 May; 33(3):1456-1463. PubMed ID: 30697823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal obesity increases insulin resistance, low-grade inflammation and osteochondrosis lesions in foals and yearlings until 18 months of age.
    Robles M; Nouveau E; Gautier C; Mendoza L; Dubois C; Dahirel M; Lagofun B; Aubrière MC; Lejeune JP; Caudron I; Guenon I; Viguié C; Wimel L; Bouraima-Lelong H; Serteyn D; Couturier-Tarrade A; Chavatte-Palmer P
    PLoS One; 2018; 13(1):e0190309. PubMed ID: 29373573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil and cytokine dysregulation in hyperinsulinemic obese horses.
    Holbrook TC; Tipton T; McFarlane D
    Vet Immunol Immunopathol; 2012 Jan; 145(1-2):283-9. PubMed ID: 22169327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paradigm shifts in understanding equine laminitis.
    Patterson-Kane JC; Karikoski NP; McGowan CM
    Vet J; 2018 Jan; 231():33-40. PubMed ID: 29429485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laminitis and the equine metabolic syndrome.
    Johnson PJ; Wiedmeyer CE; LaCarrubba A; Ganjam VK; Messer NT
    Vet Clin North Am Equine Pract; 2010 Aug; 26(2):239-55. PubMed ID: 20699172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine Disorders of the Equine Athlete.
    Frank N
    Vet Clin North Am Equine Pract; 2018 Aug; 34(2):299-312. PubMed ID: 29857965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk factors for laminitis within the Norwegian pony breed Nordlandshest/Lyngshest.
    Lykkjen S; Stenbakk LK; Holmøy IH
    Acta Vet Scand; 2023 Jun; 65(1):22. PubMed ID: 37328910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships among inflammatory cytokines, obesity, and insulin sensitivity in the horse.
    Vick MM; Adams AA; Murphy BA; Sessions DR; Horohov DW; Cook RF; Shelton BJ; Fitzgerald BP
    J Anim Sci; 2007 May; 85(5):1144-55. PubMed ID: 17264235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between hyperinsulinaemia and laminitis severity at the time of pituitary pars intermedia dysfunction diagnosis.
    Tadros EM; Fowlie JG; Refsal KR; Marteniuk J; Schott HC
    Equine Vet J; 2019 Jan; 51(1):52-56. PubMed ID: 29761574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting clinical assessment of insulin sensitivity in horses.
    Firshman AM; Valberg SJ
    Equine Vet J; 2007 Nov; 39(6):567-75. PubMed ID: 18065318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin dysregulation.
    Frank N; Tadros EM
    Equine Vet J; 2014 Jan; 46(1):103-12. PubMed ID: 24033478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equine Cushing's disease.
    McCue PM
    Vet Clin North Am Equine Pract; 2002 Dec; 18(3):533-43, viii. PubMed ID: 12516933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.